Streetbeat News

Revenues

CARA

Cara Therapeutics (NASDAQ:CARA) has received 4 analyst ratings in the last quarter, with 3 being bullish and 1 indifferent. The average 12-month price target among these analysts is $4.12, with a high of $7.00 and a low of $1.00, marking a 70.57% decline from the prior average. Analysts from HC Wainwright & Co. and Piper Sandler have lowered their price targets, reflecting changes in market conditions and company performance. Cara Therapeutics is a biotech company developing therapeutics for pain and pruritus, facing revenue challenges with a -55.0% decline over 3 months as of September 30, 2023, but has a strong net margin of -576.08% and a low debt-to-equity ratio of 0.09.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 12:00 pm

AIG

American Intl Gr (NYSE:AIG) received 9 analyst ratings in the last quarter, with an average 12-month price target of $71.44, a high estimate of $83.00, and a low estimate of $64.00. The current average has increased by 4.8% from the previous average of $68.17. Analysts have taken various actions, with some raising and others lowering their price targets. American Intl Gr is a major insurance and financial services firm with a global presence. Despite spinning off its life insurance operations, it retains a majority stake. The company has a high market capitalization and net margin but faces challenges in revenue growth and debt management.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 12:00 pm

PTEN

Patterson-UTI Energy (NASDAQ:PTEN) received 10 analyst ratings in the past quarter, with an average 12-month price target of $17.5, a high of $23.00, and a low of $12.00. The sentiment has shifted negatively, with the average price target decreasing by 4.53%. Analysts from firms including Goldman Sachs, Barclays, Piper Sandler, RBC Capital, Susquehanna, Raymond James, Morgan Stanley, B of A Securities, and Citigroup have adjusted their ratings and price targets. Patterson-UTI Energy has shown strong financial performance with a revenue growth rate of 39.03%, a net margin of 0.0%, an ROE of 0.0%, an ROA of 0.0%, and a debt-to-equity ratio of 0.28.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 12:00 pm

ACN

Accenture projects its Q2FY24 revenues to be between $15.40B and $16B, which is below the consensus estimate of $16.25B. The forecasted revenue growth is expected to be between negative 2% to 2% in local currency.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:51 am

ACN

Accenture has reaffirmed its FY24 adjusted earnings per share (EPS) guidance of $11.97-$12.32, aligning with the consensus estimate of $12.23. Additionally, the company anticipates revenue growth of 2%-5% in local currency for the same fiscal year.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:49 am

JOB

GEE Group (AMEX:JOB) reported Q4 earnings of $0.01 per share, missing the consensus estimate of $0.02 by 50%. Quarterly sales were $34.27M, falling short of the $40.35M estimate by 15.08% and representing a 17.48% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:16 am

OGI

OrganiGram Holdings (NASDAQ:OGI) reported Q4 sales of $34.33M, surpassing the $29.52M estimate by 16.29%, but saw a 1.54% decrease from the $34.87M in the same period last year. The company also reported a net loss of $24.59M.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:08 am

OPT

Opthea, a biotech company, has received an R&D tax credit of A$8.8 million (approximately $5.9 million) from the Australian Taxation Office. This financial boost acknowledges the company's research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:02 am

VGK

Eurozone CPI for November showed a month-on-month decrease of 0.6%, which is in line with estimates. The year-on-year inflation rate is 2.4%, also matching expectations.

Portfolio Pulse from Charles Gross

December 19, 2023 | 10:02 am

TSLA

Tesla, Inc. (TSLA) faces challenges in Germany as the government ends an environmental bonus, impacting electric vehicle subsidies. Tesla's Giga Berlin plant is reported to shut down from Dec. 22 to Jan. 2, 2024, potentially affecting the company's annual production target. In response to the subsidy cut, Tesla offers compensation for new Model 3/Y orders. Analyst Gordon Johnson questions Tesla's demand without government subsidies, implying overcapacity. Tesla's stock dropped slightly following the news.

Portfolio Pulse from Shanthi Rexaline

December 19, 2023 | 9:13 am